Sun, Dec 21, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

J. Paulson reassures investors, denies new CDO probe

Thursday, April 22, 2010
Opalesque Industry Update – Hedge fund manager John Paulson, chairman and founder of Paulson & Co., is taking a proactive stance with his investors in the light of the American Securities and Exchange Commission’s (SEC) probe into Goldman Sachs, as he held a second conference call in a span of three days this week with his investors.

According to CNBC, the second conference call on Wednesday involved a different group of investors and mainly touched on his letter to clients sent on Tuesday that described his dealings in the mortgage markets as “transparent and open.”

Paulson’s first conference call with clients was held on Monday.

No new CDO probe
In Wednesday’s conference call, Paulson assured his investors that the U.S. government had not launched a new collateralized debt obligations (CDOs) probe into his company. “No. Nothing that’ we’re aware of,” Paulson reportedly told his clients when asked if he received any notice from the SEC.

A day earlier, Paulson sent a letter addressed to his clients, including Australian investors, and told them that his company had always been transparent and open in its dealings with the North American housing market.

Paulson also tried to distance himself from the current controversy facing global investment bank Goldman Sachs. The Abacus security marketed by the bank is being blamed as having contributed to the sub-prime housing crisis which eventually led to the world financial meltdown in 2007 to early 2009.

Paulson is still ‘king’
Paulson found an ally with Anthony Scramucci, founder and CEO of New York-based asset management firm Skybridge Capital, who dismissed speculations that Paulson “has lost his crown.”

“Although some investors are fearful, I think any chatter about a run on Paulson's fund is very exaggerated,” Scaramucci told CNBC.

Earlier, Reuters reported that some of Paulson’s clients were considering withdrawing their money from the billionaire’s hedge fund in the face of his involvement with Goldman Sachs. The investigation into Goldman Sachs also forced Paulson’s Propel Multi-Strategy Fund in Canada to delay its planned initial public offering (IPO).

Paolo Pellegrini, a former aide of Paulson, told investigators that Paulson had a limited role in selecting the securities for the failed $1bn Abacus securities that Goldman marketed. He added that the Abacus securities were the only transaction Paulson arranged with Goldman Sachs.
-Precy Dumlao

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und